Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Luca Biologics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Luca Biologics

Luca Biologics

Seed

LUCA Biologics: Pioneering living medicines for reproductive and urogenital health.

HQ
Cambridge, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize reproductive and urogenital health, Luca Biologics is a biotechnology company focused on developing living medicines that target the vaginal microbiome. The company's vision is to harness the power of microbiome science to create innovative treatments that improve human health. Their primary products and services revolve around pioneering microbiome-based therapies designed to address various conditions affecting the reproductive and urogenital systems.

Notable figures affiliated with Luca Biologics include Dr. Alessio Fasano, a prominent member of the Seed Health Scientific Board. The company has achieved significant milestones in advancing microbiome science, contributing to a new understanding of disease treatment and prevention. Luca Biologics' work has had a substantial impact on the biotechnology sector, positioning them at the forefront of a scientific revolution in microbiome research.

Luca Biologics - Similar Companies

Seed Health logo

Seed Health

seedhealth.com

Petri Bio logo

Petri Bio

petribio.com

Vulcan Biologics logo

Vulcan Biologics

Solarea Bio logo

Solarea Bio

solareabio.com

MarvelBiome logo

MarvelBiome

marvelbiome.com

Granata Bio logo

Granata Bio

granata.bio

ResBiotic logo

ResBiotic

resbiotic.com

The BioCollective logo

The BioCollective

Notitia Biotechnologies logo

Notitia Biotechnologies

notitiabio.com

Faze Medicines logo

Faze Medicines

fazemed.com

Holobiome logo

Holobiome

holobiome.org

Aobiome logo

Aobiome

aobiome.com

BlueTurtleBio Technologies logo

BlueTurtleBio Technologies

blueturtlebio.com

Vedanta Biosciences logo

Vedanta Biosciences

vedantabio.com

Fortis Biosciences logo

Fortis Biosciences

Luca Biologics - Quick Facts

Who are Luca Biologics' competitors?

Companies similar to Luca Biologics include Seed Health, Petri Bio, Vulcan Biologics and Solarea Bio.

When was Luca Biologics founded?

Luca Biologics was founded in 2019.

Where is Luca Biologics' headquarters located?

Luca Biologics' headquarters is located in Cambridge, MA, US.

When was Luca Biologics' last funding round?

Luca Biologics' most recent funding round was for $2.8M (USD) in August 2019.

How much has Luca Biologics raised to-date?

As of Aug 7, 2019, Luca Biologics has raised a total of $2.8M (USD).

How many employees does Luca Biologics have?

Luca Biologics has 9 employees as of Feb 4, 2024.

Luca Biologics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • Biotechnology
  • Therapeutics
Tags
  • Biotechnology
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software